SABA, Francesca
SABA, Francesca
SCIENZE MEDICHE
Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications
2022-01-01 Felicetti F.; Aimaretti E.; Dal Bello F.; Gatti F.; Godono A.; Saba F.; Einaudi G.; Collino M.; Fagioli F.; Aragno M.; Brignardello E.
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease
2015-01-01 Saponaro, C; Gaggini, M; Rosso, C; Buzzigoli, E; Carli, F; Ciociaro, D; Mezzabotta, L; Vanni, E; Saba, F; Abate, M; Smedile, A; Rizzetto, M; Bugianesi, E; Gastaldelli, A
After oral fat load NAFLD subjects and healthy controls show different serum free fatty acid trends.
2014-01-01 R. Gambino; E. Bugianesi; C. Rosso; L. Mezzabotta; S. Pinach; N. Alemanno; F. Saba; M. Cassader
Alteration in glucose metabolism after an oral glucose load and relationship with liver damage in patients with NAFLD.
2014-01-01 E. Vanni; L. Mezzabotta; C. Rosso; M. Gaggini; R. Gambino; F. Salomone; E. Buzzigoli; C. Saponaro; F. Saba; D. Ciociaro; G.P. Caviglia; M.L. Abate; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi.
Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease.
2014-01-01 E. Vanni; L. Mezzabotta; C. Rosso; M. Gaggini; R. Gambino; F. Salomone; E. Buzzigoli; C. Saponaro; F. Saba; D. Ciociaro; G.P. Caviglia; M.L. Abate; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi.
Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease.
2014-01-01 L. Mezzabotta; E. Vanni; C. Rosso; M. Gaggini; R. Gambino; E. Buzzigoli; C. Saponaro; D. Ciociaro; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi.
Alteration in lipid metabolism after an oral fat load in patients with NAFLD.
2014-01-01 L. Mezzabotta; E. Vanni; C. Rosso; M. Gaggini; R. Gambino; E. Buzzigoli; C. Saponaro; D. Ciociaro; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi
Alteration in lipid metabolism after an oral fat load in subjects with NAFLD.
2013-01-01 Gastaldelli A.; Gaggini M.; Mezzabotta L.; Rosso C.; Carli F.; Ciociaro D.; Gambino R.; Carenzi S.; Saba F.; Cassader M.; Bugianesi E
Analytical and clinical comparison between two different analytical methods for the measurement of circulating insulin in patients with metabolic-dysfunction associated steatotic liver disease
2024-01-01 Francesca Saba, Marilù Benedetta Scalici, Irene Cottone, Chiara Rosso, Elisabetta Bugianesi
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation
2019-01-01 Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Paschetta, Elena; De Michieli, Franco; Pinach, Silvia; Framarin, Luciana; Berrutti, Mara; Leone, Nicola; Parente, Renato; Ayoubi Khajekini, Mohammad Taghi; Zarovska, Adriana; Gambino, Roberto
Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
2020-01-01 Musso, Giovanni; Sircana, Antonio; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto
Compositional Characteristics and Antioxidant Activity of Edible Rose Flowers and Their Effect on Phenolic Urinary Excretion
2021-01-01 Devecchi A.; Demasi S.; Saba F.; Rosato R.; Gambino R.; Ponzo V.; de Francesco A.; Massarenti P.; Bo S.; Scariot V.
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE
2015-01-01 C. Rosso; C. Saponaro; L. Mezzabotta; E. Vanni; R. Gambino; F. Saba; R. Ibrahim Kamal Jouness; M. Gaggini; E. Buzzigoli; G.P. Caviglia; M.L. Abate; F. Salomone; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi.
Diabetic ketoacidosis with SGLT2 inhibitors
2020-01-01 Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load
2016-01-01 Gambino, Roberto; Bugianesi, Elisabetta; Rosso, Chiara; Mezzabotta, Lavinia; Pinach, Silvia; Alemanno, Natalina; Saba, Francesca; Cassader, Maurizio
Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis.
2011-01-01 Musso G; Cassader M; De Michieli F; Saba F; Bo S; Gambino R
Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial
2024-01-01 Musso, Giovanni; Pinach, Silvia; Mariano, Filippo; Saba, Francesca; De Michieli, Franco; Framarin, Luciana; Berrutti, Mara; Paschetta, Elena; Parente, Renato; Lizet Castillo, Yanina; Leone, Nicola; Castellino, Francesca; Cassader, Maurizio; Gambino, Roberto
Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
2017-01-01 Bo, S; Ponzo, V.; Evangelista, A.; Ciccone, G.; Goitre, I.; Saba, F.; Procopio, M.; Cassader, M.; Gambino, R.
Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease.
2014-01-01 C. Rosso; E. Vanni; L. Mezzabotta; R. Gambino; F. Saba; S. Carenzi; A. Gastaldelli; M. Gaggini; E. Buzzigoli; C. Saponaro; F. Carli; G.P. Caviglia; M.L. Abate; F. Salamone; A. Smedile; M. Rizzetto; M. Cassader; E. Bugianesi
EFFICACIA DELLA CURCUMINA NEL TRATTAMENTO DELLA STEATOSI EPATICA NON ALCOLICA (NAFLD). EFFECT OF CURCUMIN FOR NONALCOHOLIC STEATO-EPATITIS
2022-07-10
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications | 2022 | Felicetti F.; Aimaretti E.; Dal Bello F.; Gatti F.; Godono A.; Saba F.; Einaudi G.; Collino M.; Fagioli F.; Aragno M.; Brignardello E. | |
| Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease | 2015 | Saponaro, C; Gaggini, M; Rosso, C; Buzzigoli, E; Carli, F; Ciociaro, D; Mezzabotta, L; Vanni, E; Saba, F; Abate, M; Smedile, A; Rizzetto, M; Bugianesi, E; Gastaldelli, A | |
| After oral fat load NAFLD subjects and healthy controls show different serum free fatty acid trends. | 2014 | R. Gambino; E. Bugianesi; C. Rosso; L. Mezzabotta; S. Pinach; N. Alemanno; F. Saba; M. Cassader | |
| Alteration in glucose metabolism after an oral glucose load and relationship with liver damage in patients with NAFLD. | 2014 | E. Vanni; L. Mezzabotta; C. Rosso; M. Gaggini; R. Gambino; F. Salomone; E. Buzzigoli; C. Saponaro; F. Saba; D. Ciociaro; G.P. Caviglia; M.L. Abate; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi. | |
| Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease. | 2014 | E. Vanni; L. Mezzabotta; C. Rosso; M. Gaggini; R. Gambino; F. Salomone; E. Buzzigoli; C. Saponaro; F. Saba; D. Ciociaro; G.P. Caviglia; M.L. Abate; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi. | |
| Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease. | 2014 | L. Mezzabotta; E. Vanni; C. Rosso; M. Gaggini; R. Gambino; E. Buzzigoli; C. Saponaro; D. Ciociaro; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi. | |
| Alteration in lipid metabolism after an oral fat load in patients with NAFLD. | 2014 | L. Mezzabotta; E. Vanni; C. Rosso; M. Gaggini; R. Gambino; E. Buzzigoli; C. Saponaro; D. Ciociaro; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; S. Carenzi; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi | |
| Alteration in lipid metabolism after an oral fat load in subjects with NAFLD. | 2013 | Gastaldelli A.; Gaggini M.; Mezzabotta L.; Rosso C.; Carli F.; Ciociaro D.; Gambino R.; Carenzi S.; Saba F.; Cassader M.; Bugianesi E | |
| Analytical and clinical comparison between two different analytical methods for the measurement of circulating insulin in patients with metabolic-dysfunction associated steatotic liver disease | 2024 | Francesca Saba, Marilù Benedetta Scalici, Irene Cottone, Chiara Rosso, Elisabetta Bugianesi | |
| Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation | 2019 | Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Paschetta, Elena; De Michieli, Franco; Pinach, Silvia; Framarin, Luciana; Berrutti, Mara; Leone, Nicola; Parente, Renato; Ayoubi Khajekini, Mohammad Taghi; Zarovska, Adriana; Gambino, Roberto | |
| Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression | 2020 | Musso, Giovanni; Sircana, Antonio; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto | |
| Compositional Characteristics and Antioxidant Activity of Edible Rose Flowers and Their Effect on Phenolic Urinary Excretion | 2021 | Devecchi A.; Demasi S.; Saba F.; Rosato R.; Gambino R.; Ponzo V.; de Francesco A.; Massarenti P.; Bo S.; Scariot V. | |
| DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE | 2015 | C. Rosso; C. Saponaro; L. Mezzabotta; E. Vanni; R. Gambino; F. Saba; R. Ibrahim Kamal Jouness; M. Gaggini; E. Buzzigoli; G.P. Caviglia; M.L. Abate; F. Salomone; A. Smedile; M. Rizzetto; M. Cassader; A. Gastaldelli; E. Bugianesi. | |
| Diabetic ketoacidosis with SGLT2 inhibitors | 2020 | Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto | |
| Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load | 2016 | Gambino, Roberto; Bugianesi, Elisabetta; Rosso, Chiara; Mezzabotta, Lavinia; Pinach, Silvia; Alemanno, Natalina; Saba, Francesca; Cassader, Maurizio | |
| Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis. | 2011 | Musso G; Cassader M; De Michieli F; Saba F; Bo S; Gambino R | |
| Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial | 2024 | Musso, Giovanni; Pinach, Silvia; Mariano, Filippo; Saba, Francesca; De Michieli, Franco; Framarin, Luciana; Berrutti, Mara; Paschetta, Elena; Parente, Renato; Lizet Castillo, Yanina; Leone, Nicola; Castellino, Francesca; Cassader, Maurizio; Gambino, Roberto | |
| Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial | 2017 | Bo, S; Ponzo, V.; Evangelista, A.; Ciccone, G.; Goitre, I.; Saba, F.; Procopio, M.; Cassader, M.; Gambino, R. | |
| Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease. | 2014 | C. Rosso; E. Vanni; L. Mezzabotta; R. Gambino; F. Saba; S. Carenzi; A. Gastaldelli; M. Gaggini; E. Buzzigoli; C. Saponaro; F. Carli; G.P. Caviglia; M.L. Abate; F. Salamone; A. Smedile; M. Rizzetto; M. Cassader; E. Bugianesi | |
| EFFICACIA DELLA CURCUMINA NEL TRATTAMENTO DELLA STEATOSI EPATICA NON ALCOLICA (NAFLD). EFFECT OF CURCUMIN FOR NONALCOHOLIC STEATO-EPATITIS | 2022 | - |